BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 29045731)

  • 1. The Chimpanzee Model of Viral Hepatitis: Advances in Understanding the Immune Response and Treatment of Viral Hepatitis.
    Lanford RE; Walker CM; Lemon SM
    ILAR J; 2017 Dec; 58(2):172-189. PubMed ID: 29045731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The chimpanzee model of hepatitis C virus infections.
    Lanford RE; Bigger C; Bassett S; Klimpel G
    ILAR J; 2001; 42(2):117-26. PubMed ID: 11406714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV.
    Forns X; Payette PJ; Ma X; Satterfield W; Eder G; Mushahwar IK; Govindarajan S; Davis HL; Emerson SU; Purcell RH; Bukh J
    Hepatology; 2000 Sep; 32(3):618-25. PubMed ID: 10960458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human monoclonal antibody HCV1 effectively prevents and treats HCV infection in chimpanzees.
    Morin TJ; Broering TJ; Leav BA; Blair BM; Rowley KJ; Boucher EN; Wang Y; Cheslock PS; Knauber M; Olsen DB; Ludmerer SW; Szabo G; Finberg RW; Purcell RH; Lanford RE; Ambrosino DM; Molrine DC; Babcock GJ
    PLoS Pathog; 2012; 8(8):e1002895. PubMed ID: 22952447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advancement in the development of models for hepatitis C research.
    Carcamo WC; Nguyen CQ
    J Biomed Biotechnol; 2012; 2012():346761. PubMed ID: 22701302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection.
    Bassett SE; Guerra B; Brasky K; Miskovsky E; Houghton M; Klimpel GR; Lanford RE
    Hepatology; 2001 Jun; 33(6):1479-87. PubMed ID: 11391537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and immunological significance of chimpanzee major histocompatibility complex haplotypes for hepatitis C virus immune response and vaccination studies.
    Mizukoshi E; Nascimbeni M; Blaustein JB; Mihalik K; Rice CM; Liang TJ; Feinstone SM; Rehermann B
    J Virol; 2002 Jun; 76(12):6093-103. PubMed ID: 12021342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of hepatitis C virus in chimpanzees and their importance for vaccine development.
    Bukh J; Forns X; Emerson SU; Purcell RH
    Intervirology; 2001; 44(2-3):132-42. PubMed ID: 11509874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The chimpanzee model for hepatitis B virus infection.
    Wieland SF
    Cold Spring Harb Perspect Med; 2015 Jun; 5(6):. PubMed ID: 26033082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An assessment of the use of chimpanzees in hepatitis C research past, present and future: 1. Validity of the chimpanzee model.
    Bailey J
    Altern Lab Anim; 2010 Oct; 38(5):387-418. PubMed ID: 21105756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Previously infected and recovered chimpanzees exhibit rapid responses that control hepatitis C virus replication upon rechallenge.
    Major ME; Mihalik K; Puig M; Rehermann B; Nascimbeni M; Rice CM; Feinstone SM
    J Virol; 2002 Jul; 76(13):6586-95. PubMed ID: 12050371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of hepatitis C virus-inoculated chimpanzees reveals unexpected clinical profiles.
    Bassett SE; Brasky KM; Lanford RE
    J Virol; 1998 Apr; 72(4):2589-99. PubMed ID: 9525575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus JFH-1 strain infection in chimpanzees is associated with low pathogenicity and emergence of an adaptive mutation.
    Kato T; Choi Y; Elmowalid G; Sapp RK; Barth H; Furusaka A; Mishiro S; Wakita T; Krawczynski K; Liang TJ
    Hepatology; 2008 Sep; 48(3):732-40. PubMed ID: 18712792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell therapy for chronic viral hepatitis.
    Bertoletti A; Tan AT; Koh S
    Cytotherapy; 2017 Nov; 19(11):1317-1324. PubMed ID: 28847469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative features of hepatitis C virus infection in humans and chimpanzees.
    Walker CM
    Springer Semin Immunopathol; 1997; 19(1):85-98. PubMed ID: 9266633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory.
    Swadling L; Capone S; Antrobus RD; Brown A; Richardson R; Newell EW; Halliday J; Kelly C; Bowen D; Fergusson J; Kurioka A; Ammendola V; Del Sorbo M; Grazioli F; Esposito ML; Siani L; Traboni C; Hill A; Colloca S; Davis M; Nicosia A; Cortese R; Folgori A; Klenerman P; Barnes E
    Sci Transl Med; 2014 Nov; 6(261):261ra153. PubMed ID: 25378645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Robust antiviral efficacy upon administration of a nucleoside analog to hepatitis C virus-infected chimpanzees.
    Carroll SS; Ludmerer S; Handt L; Koeplinger K; Zhang NR; Graham D; Davies ME; MacCoss M; Hazuda D; Olsen DB
    Antimicrob Agents Chemother; 2009 Mar; 53(3):926-34. PubMed ID: 19075052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A critical role for the chimpanzee model in the study of hepatitis C.
    Bukh J
    Hepatology; 2004 Jun; 39(6):1469-75. PubMed ID: 15185284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of CD4+ and CD8+ memory T-cell responses during hepatitis C virus rechallenge of previously recovered chimpanzees.
    Nascimbeni M; Mizukoshi E; Bosmann M; Major ME; Mihalik K; Rice CM; Feinstone SM; Rehermann B
    J Virol; 2003 Apr; 77(8):4781-93. PubMed ID: 12663785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of the virus specific T-cell response in acute and chronic HBV and HCV infection].
    Panther E; Spangenberg HC; Neumann-Haefelin C; Rösler K; Blum HE; von Weizsäcker F; Thimme R
    Z Gastroenterol; 2004 Jan; 42(1):39-46. PubMed ID: 14997402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.